Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-16-016103)

Filing Details

Accession Number:: 0001493152-16-016103
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-12-21 16:03:42
Reporting Period:: 2016-12-19

Filing Date:: 2016-12-21
Accepted Time:: 2016-12-21 16:03:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1360214	Imprimis Pharmaceuticals Inc.	IMMY	Pharmaceutical Preparations (2834)	450567010

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1542150	R. Andrew Boll	C/O Imprimis Pharmaceuticals, Inc. 12264 El Camino Real, Suite 350 San Diego CA 92130	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-12-19	39,000	$1.79	54,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Purchase Warrant	Acquisiton	2016-12-19	39,000	$0.13	39,000	$1.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
39,000	2016-06-23	2019-12-23	No	4	P	Direct

Footnotes

On December 19, 2016, Mr. Boll entered into a definitive agreement to acquire 39,000 Units of Imprimis Pharmaceuticals, Inc.'s (the "Company"), with each Unit consisting of one share of common stock, and a warrant to purchase one share of the Company's common stock, as part of a private placement by the Company to accredited investors.
The value of the Purchase Warrant included in each Unit is $0.125.